ERBB2 and neoplasm: In a xenograft mouse model of MB and ependymoma, the administration of EPHA2, HER2, or ILRα13 CAR T cells in the CSF was an effective treatment, increasing the amount of CAR T cells in contact with the tumour cells and decreasing toxicities [85].